Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...
Free White Paper

>> Download now...

Biotech in China
Biotech in China

Free from Nature

>> Download now...

ShangPharma Achieves First Milestone in Hengrui Biologics Partnership

publication date: Jan 19, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
ShangPharma, the pre-clinical CRO based in Shanghai, attained the first milestone in its strategic partnership with Jiangsu Hengrui Medicine Co. The partnership, which was announced just four months ago in September 2011, is developing novel therapeutic monoclonal antibodies for an unspecified disease area. More details....

Stock Symbol: (NYSE: SHP)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners